Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Addex Therapeutics (ADXN) Short-term Investments (2018 - 2025)

Addex Therapeutics' Short-term Investments history spans 8 years, with the latest figure at $6418.5 for Q4 2025.

  • On a quarterly basis, Short-term Investments fell 13.44% to $6418.5 in Q4 2025 year-over-year; TTM through Dec 2025 was $6418.5, a 13.44% decrease, with the full-year FY2025 number at $6187.4, down 16.56% from a year prior.
  • Short-term Investments came in at $6418.5 for Q4 2025, down from $8575.8 in the prior quarter.
  • The five-year high for Short-term Investments was $42007.1 in Q2 2021, with the low at $482.3 in Q3 2023.
  • Historically, Short-term Investments has averaged $9802.5 across 5 years, with a median of $6916.9 in 2025.
  • Biggest five-year swings in Short-term Investments: crashed 91.2% in 2022 and later surged 1083.65% in 2024.
  • Year by year, Short-term Investments stood at $18593.8 in 2021, then tumbled by 82.33% to $3285.3 in 2022, then tumbled by 70.9% to $956.0 in 2023, then soared by 675.66% to $7415.3 in 2024, then dropped by 13.44% to $6418.5 in 2025.
  • Business Quant data shows Short-term Investments for ADXN at $6418.5 in Q4 2025, $8575.8 in Q3 2025, and $8448.0 in Q2 2025.